Detalles de la búsqueda
1.
Synthesis and pharmacological characterization of constrained analogues of Vestipitant as in vitro potent and orally active NK(1) receptor antagonists.
Bioorg Med Chem Lett
; 20(2): 623-7, 2010 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19963378
2.
Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor.
Farmaco
; 60(5): 393-7, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15885689
3.
Benzoazepine derivative as potent antagonists of the glycine binding site associated to the NMDA receptor.
Farmaco
; 58(9): 723-38, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-13679166
4.
Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist.
J Med Chem
; 52(10): 3238-47, 2009 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-19388677
5.
Chiral tetrahydroquinoline derivatives as potent anti-hyperalgesic agents in animal models of sustained inflammation and chronic neuropathic pain.
Bioorg Med Chem Lett
; 17(5): 1176-80, 2007 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17218099
6.
Novel carbazole derivatives as NPY Y1 antagonists.
Bioorg Med Chem Lett
; 17(4): 1043-6, 2007 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17127055
7.
Enantiomerically pure tetrahydroquinoline derivatives as in vivo potent antagonists of the glycine binding site associated to the NMDA receptor.
Bioorg Med Chem Lett
; 13(21): 3863-6, 2003 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-14552796
Resultados
1 -
7
de 7
1
Próxima >
>>